What did a meta-analysis conclude about Lactobacillus GG in pediatric patients?

What did a meta-analysis conclude about Lactobacillus GG in pediatric patients?

• A. Not safe in pediatric populations
• B. Effective for Helicobacter pylori infection in children
• C. Effective for NEC in infants
• D. Safe and effective for treating acute infectious diarrhea in children

Answer: (D)

Lactobacillus GG is a probiotic that is generally safe for children and can help shorten the course of acute infectious diarrhea. A meta-analysis of pediatric trials found that this probiotic is safe in children and effective for treating acute infectious diarrhea, typically reducing the duration of diarrhea and related symptoms. The focus here is on this specific outcome in pediatric patients, not on other conditions. While there is interest in potential benefits for conditions like NEC in infants or H. pylori infection in children, the strongest, most consistent evidence from the analyzed pediatric data supports its safety and efficacy for acute infectious diarrhea. Rare adverse events can occur in very ill or immunocompromised individuals, but for the general pediatric population, it is considered safe.

Lactobacillus GG is a probiotic that is generally safe for children and can help shorten the course of acute infectious diarrhea. A meta-analysis of pediatric trials found that this probiotic is safe in children and effective for treating acute infectious diarrhea, typically reducing the duration of diarrhea and related symptoms. The focus here is on this specific outcome in pediatric patients, not on other conditions. While there is interest in potential benefits for conditions like NEC in infants or H. pylori infection in children, the strongest, most consistent evidence from the analyzed pediatric data supports its safety and efficacy for acute infectious diarrhea. Rare adverse events can occur in very ill or immunocompromised individuals, but for the general pediatric population, it is considered safe.